|
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
||||||||||||||||||||||||||||||||||||
| Sponsor: | Rambam Health Care Campus |
|---|---|
| Information provided by: | Rambam Health Care Campus |
| ClinicalTrials.gov Identifier: | NCT00270322 |
Purpose
The study purpose is to compare the effectiveness of different methods for post-operative pain treatment after total knee replacement.
| Condition | Intervention | Phase |
|---|---|---|
|
Pain, Postoperative Osteoarthritis |
Drug: Marcaine 0.166% + Fentanyl 3.33 mcg/ml Drug: Morphine sulphate |
Phase IV |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Safety/Efficacy Study Intervention Model: Parallel Assignment Masking: Double-Blind Primary Purpose: Treatment |
| Official Title: | Pain Treatment After Total Knee Replacement - Continuous Epidural Versus Intravenous Patient Controlled Analgesia With Morphine |
| Estimated Enrollment: | 80 |
| Study Start Date: | January 2006 |
| Study Completion Date: | March 2007 |
Total knee replacement (TKR) is known to be one of the most painful surgical procedures. Many treatments have been used post TKR: IV opioids, epidural infusions, peripheral nerve blocks. No one method has been recognised as the best one.
In this study we will compare two well established methods of pain treatment:
The study design is double blind.
Patients will have a combined spinal-epidural anesthesia for the operation and then will be connected to 2 different pumps, one to the epidural catheter and one to the intravenous catheter, for the first 24 hours post-operatively.
Pain scores, total analgesic medications other than study medications, adverse reactions to study medications, complications and patient satisfaction will be followed by blinded observers and compared between groups.
Eligibility| Ages Eligible for Study: | 55 Years to 85 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contacts and Locations
More Information
| ClinicalTrials.gov Identifier: | NCT00270322 History of Changes |
| Other Study ID Numbers: | TKR-1.CTIL |
| Study First Received: | December 23, 2005 |
| Last Updated: | April 10, 2007 |
| Health Authority: | Israel: Israeli Health Ministry Pharmaceutical Administration |
|
total knee replacement orthopedic surgery post operative analgesia continuous epidural patients controlled analgesia morphine |
combined spinal epidural anesthesia anesthesia analgesia epidural marcaine epidural fentanyl pain |
|
Osteoarthritis Pain, Postoperative Arthritis Joint Diseases Musculoskeletal Diseases Rheumatic Diseases Postoperative Complications Pathologic Processes Pain Signs and Symptoms Bupivacaine Fentanyl Morphine Anesthetics, Local |
Anesthetics Central Nervous System Depressants Physiological Effects of Drugs Pharmacologic Actions Sensory System Agents Peripheral Nervous System Agents Central Nervous System Agents Therapeutic Uses Adjuvants, Anesthesia Narcotics Analgesics Anesthetics, Intravenous Anesthetics, General Analgesics, Opioid |